Haoxi Health Technology (HAO) Cash & Equivalents (2023 - 2025)

Haoxi Health Technology's Cash & Equivalents history runs 3 years deep, the most recent figure standing at $6.8 million for Q4 2025.

• In Q4 2025, Cash & Equivalents fell 25.23% year-over-year to $6.8 million; the TTM figure through Dec 2025 stood at $6.8 million (down 25.23% YoY), while the FY2025 annual figure was $8.6 million, up 29.49% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $6.8 million, down from $8.6 million in the prior quarter.
• The five-year high for Cash & Equivalents was $9.1 million in Q4 2024, with the low at $1.2 million in Q2 2023.
• The 3-year median for Cash & Equivalents is $6.8 million (2025), against an average of $6.5 million.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents soared 453.17% in 2024, then retreated 25.23% in 2025.
• Haoxi Health Technology's Cash & Equivalents stood at $1.2 million in 2023, then jumped by 656.02% to $9.1 million in 2024, then slipped by 25.23% to $6.8 million in 2025.
• Business Quant data shows HAO's Cash & Equivalents at $6.8 million in Q4 2025, $8.6 million in Q2 2025, and $9.1 million in Q4 2024.